Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or South Carolina for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to South Carolina only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. South Carolina (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Richard Kim (NPI 1699748459)

Field	Value
Entity Type	Individual
Organization	Richard Kim
Address	3 Saint Francis Dr Ste 400
City	Greenville
State	SC
ZIP	29601
Taxonomy	Rheumatology Physician
NPI Enumerated	February 10, 2006

Payer Source	Total Paid
Medicare	$3.6M
Medicaid	$0

Key Findings

Provider tenure and payer mix: RICHARD KIM has an NPI enumerated on 2006-02-10 (~20 years ago) and reports Total Medicare revenue of $3.6M with no Medicaid billing on file. The absence of Medicaid activity makes this effectively a single-payer (Medicare) revenue profile, concentrating payment exposure to the Medicare population.

Revenue concentration is high and focused in a few biologic drug codes: the precomputed top three Medicare codes (J0129, J0717, J1602) account for 50.8% of this provider’s total Medicare revenue. Individually those top three are J0129 $674K (18.9%), J0717 $579.2K (16.2%), and J1602 $563.5K (15.8%), indicating a large share of revenue is driven by a small set of injectable biologics.

Business and service-line implication: the code mix is dominated by biologic J‑codes (for example J0129, J0717, J1602, J9312, J1745, J3262), which is consistent with an in‑office infusion/administration model treating autoimmune and related conditions. Evaluation-and-management CPTs generate a comparatively small share of revenue (for example 99214 $82.8K, 2.3%), which suggests the practice’s economics rely more on drug administration and infusion services than on routine office visits.

Infusion and chemotherapy administration activity is an important operational feature: the provider reports 96413 $100K (2.8%) and 96401 $47.4K (1.3%), with 96413 characterized as an "extreme outlier, far above typical national volume" (99th percentile) and 96401 as "notably above typical national volume" (98th percentile). High-volume add-on and infusion-continuation codes such as 96415 $7.9K (0.2%) also rank in the 98th percentile, reinforcing that extended or repeated infusion services are a material part of the practice.

Competitive standing by drug: for some high-revenue J‑codes this provider ranks well above peers nationally — J1602 ranks #37 of 1041 providers (97th percentile; noted as "notably above typical national volume") and J1745 ranks #61 of 1352 providers (96th percentile; "notably above typical national volume"). These rankings indicate the provider is a major national participant for specific infusion drugs rather than a marginal operator for those items.

At the same time, several biologic J‑codes appear at high percentiles but are labeled "typical, unremarkable volume," for example J0129 ranks #129 of 1221 (90th percentile; typical, unremarkable volume) and J0717 ranks #69 of 848 (92th percentile; typical, unremarkable volume). That combination suggests the provider’s volumes are substantial in raw terms, yet within the expected distribution for many commonly administered biologics.

Practice risk and strategic notes: with Total Medicare revenue of $3.6M and no reported Medicaid billing, the practice is exposed to Medicare policy and reimbursement changes that affect in‑office drug administration. Given that a narrow set of high-cost injectable drugs drive a majority of revenue (top three codes account for 50.8%), any shifts in coverage, reimbursement, or drug mix could materially affect revenue.

Operational profile supported by mid/low E/M and ancillary services: beyond biologics and infusion codes, the practice bills routine diagnostics and support items (examples include 85025 $7K, 77080 $4.4K and DXA codes), indicating a full-service outpatient infusion clinic that also performs relevant monitoring and lab work to support biologic therapy management.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

32 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	20,430	$30	$674K
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	144,800	$1	$579.2K
J1602	Injection, golimumab, 1 mg, for intravenous use	56,350	$10	$563.5K
J9312	Injection, rituximab, 10 mg	5,960	$60	$381.4K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	11,970	$30	$311.2K
J3262	Injection, tocilizumab, 1 mg	48,440	$10	$242.2K
J0897	Injection, denosumab, 1 mg	11,340	$20	$204.1K
J0490	Injection, belimumab, 10 mg	5,740	$40	$200.9K
J3111	Injection, romosozumab-aqqg, 1 mg	17,430	$10	$139.4K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	1,080	$90	$100K

Showing 1–10 of 32

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 32 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. South Carolina Distribution

Richard Kim — 4 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — South Carolina

Full comparison — all codes billed, vs. state median

32 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	6	40	9,640	$30	$424.2K
J0717	5	20	59,200	$1	$278.4K
J1602	3	40	23,560	$10	$264.5K
J3262	13	20	40,900	$1	$202.7K
J9312	2	20	2,340	$60	$193.7K
J0490	1	10	4,820	$40	$152K
J3111	29	40	12,390	$10	$129.4K
J1745	4	50	3,250	$30	$107K
J0897	48	250	2,400	$20	$91.2K
99214	313	7,860	160	$80	$23.2K

Showing 1–10 of 32

Related Providers

Other providers that share a Tax Identification Number (TIN) with Richard Kim, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Jefferson Regional Medical Center	PA	General Acute Care Hospital	$0	$12.7M
West Penn Allegheny Health System Inc.	PA	General Acute Care Hospital	$0	$8.2M
Suhail Kumar	SC	Rheumatology Physician	$3.4M	$0
Long Huynh-duc	SC	Rheumatology Physician	$3.2M	$0
Corey Ephrussi	SC	Rheumatology Physician	$1.8M	$1.2K
Thierry Verstraeten	PA	Ophthalmology Physician	$894.3K	$45K
Allegheny Clinic	PA	Radiology Clinic/Center	$842K	$0
Myles Mitsunaga	CA	Diagnostic Radiology Physician	$510.8K	$113.9K
Carol Mayfield	PA	Family Nurse Practitioner	$568.5K	$0
Angela Stupi	PA	Rheumatology Physician	$472.5K	$27.1K

Nearby Providers

Other providers in the same ZIP code as Richard Kim, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
South Carolina Dept Of Mental Health Accounting Office	SC	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$61.9M
Prisma Health-upstate	SC	Developmental Disabilities Clinic/Center	$0	$19.7M
St Francis Hospital Inc	SC	General Acute Care Hospital	$0	$17.8M
South Carolina Dept Of Mental Health Accounting Office	SC	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$13.8M
County Of Greenville	SC	Land Ambulance	$4.2M	$9.2M
Greenville Proaxis Therapy, LLC	SC	Physical Therapist	$0	$7.9M
Carolina Family Services, Inc.	SC	Community/Behavioral Health Agency	$0	$5.5M
Ahead Start LLC	SC	Early Intervention Provider Agency	$0	$4.5M
Greenville Health System	SC	Medically Fragile Infants and Children Day Care	$0	$4.2M
Vituity-south Carolina LLC	SC	Emergency Medicine Physician	$0	$4.1M

Richard Kim — Billing Profile & Reimbursement Data

Sign up for Richard Kim — Billing Profile & Reimbursement Data policy alerts

Richard Kim — Billing Profile & Reimbursement Data

Sign up for Richard Kim — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References